The unlikely story of how an Ebola vaccine came to be
After an Ebola outbreak began in West Africa in 2014, it took only a few years to test and approve a vaccine for the virus, a staggering speed when it comes to vaccine development. Today, Merck has an approved product.
But, as STAT’s Helen Branswell reports, the seeming overnight success in Ebola has roots dating back three decades marked by scientific inspiration, personal dedication, and a series of roadblocks that almost guaranteed failure.
“This vaccine … from the beginning to the end — it should have never happened. On so many levels … against all odds, it made it,” one scientist said.
Read more.
But, as STAT’s Helen Branswell reports, the seeming overnight success in Ebola has roots dating back three decades marked by scientific inspiration, personal dedication, and a series of roadblocks that almost guaranteed failure.
“This vaccine … from the beginning to the end — it should have never happened. On so many levels … against all odds, it made it,” one scientist said.
Read more.
.png)
No hay comentarios:
Publicar un comentario